IVAWe are retracing to the 200 Ma which also happens to be the 1.272 fib. this offers a short opportunity of 8.57%.
Nothing I say is financial advice.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.065 EUR
−110.43 M EUR
17.48 M EUR
61.31 M
About INVENTIVA
Sector
Industry
CEO
Frédéric Cren
Website
Headquarters
Daix
Founded
2011
ISIN
FR0013233012
FIGI
BBG00JHW7WB9
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Possibility of strong rise, but beware of speculatorsThis increase of more than 30% of November 1 is not obtained as a result of news concerning Inventiva, caution, therefore, following the speculators who can in the short term vary the action.
In the long run, I think it's a big possibility if the products work and the tests succeed one after the ot
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0RNK is 2.420 EUR — it has increased by 1.04% in the past 24 hours. Watch INVENTIVA SA EUR0.01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange INVENTIVA SA EUR0.01 stocks are traded under the ticker 0RNK.
0RNK stock has fallen by −3.97% compared to the previous week, the month change is a 65.75% rise, over the last year INVENTIVA SA EUR0.01 has showed a −33.06% decrease.
We've gathered analysts' opinions on INVENTIVA SA EUR0.01 future price: according to them, 0RNK price has a max estimate of 14.00 EUR and a min estimate of 4.40 EUR. Watch 0RNK chart and read a more detailed INVENTIVA SA EUR0.01 stock forecast: see what analysts think of INVENTIVA SA EUR0.01 and suggest that you do with its stocks.
0RNK reached its all-time high on Feb 9, 2021 with the price of 14.900 EUR, and its all-time low was 1.460 EUR and was reached on Oct 8, 2024. View more price dynamics on 0RNK chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RNK stock is 1.04% volatile and has beta coefficient of 0.89. Track INVENTIVA SA EUR0.01 stock price on the chart and check out the list of the most volatile stocks — is INVENTIVA SA EUR0.01 there?
Today INVENTIVA SA EUR0.01 has the market capitalization of 211.17 M, it has increased by 2.86% over the last week.
Yes, you can track INVENTIVA SA EUR0.01 financials in yearly and quarterly reports right on TradingView.
INVENTIVA SA EUR0.01 is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
0RNK earnings for the last half-year are −0.94 EUR per share, whereas the estimation was −1.22 EUR, resulting in a 22.95% surprise. The estimated earnings for the next half-year are −0.91 EUR per share. See more details about INVENTIVA SA EUR0.01 earnings.
INVENTIVA SA EUR0.01 revenue for the last half-year amounts to 41.00 K EUR, despite the estimated figure of 0.00 EUR. In the next half-year revenue is expected to reach 1.88 M EUR.
0RNK net income for the last half-year is −49.03 M EUR, while the previous report showed −55.16 M EUR of net income which accounts for 11.11% change. Track more INVENTIVA SA EUR0.01 financial stats to get the full picture.
No, 0RNK doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 123.00 employees. See our rating of the largest employees — is INVENTIVA SA EUR0.01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INVENTIVA SA EUR0.01 EBITDA is −101.28 M EUR, and current EBITDA margin is −603.54%. See more stats in INVENTIVA SA EUR0.01 financial statements.
Like other stocks, 0RNK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INVENTIVA SA EUR0.01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INVENTIVA SA EUR0.01 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INVENTIVA SA EUR0.01 stock shows the sell signal. See more of INVENTIVA SA EUR0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.